Highline Wealth Partners’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.22K Hold
75
﹤0.01% 989
2026
Q1
$2.89K Buy
+75
New +$3.09K ﹤0.01% 917

Other funds holding BME

Highline Wealth Partners's BME Position: Q2 2026 in Review

Highline Wealth Partners held its BlackRock Health Sciences Trust (BME) position steady in Q2 2026 at 75 shares worth $3.22K. The position accounts for ﹤0.01% of the portfolio, ranked #989.

Highline Wealth Partners first reported a position in BME in Q1 2026 and has held it in 2 quarters since. 17 funds tracked by Wall St. Rank hold BME as of Q2 2026.

  • Highline Wealth Partners held 75 shares of BlackRock Health Sciences Trust worth $3.22K as of Q2 2026.
  • Highline Wealth Partners left its BlackRock Health Sciences Trust share count unchanged in Q2 2026.
  • BlackRock Health Sciences Trust made up ﹤0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #989 holding.
  • Highline Wealth Partners first reported a position in BlackRock Health Sciences Trust in Q1 2026 and has held it in 2 quarters since.
  • 17 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.